OTC Link · Healthcare · Drug Manufacturers - Specialty & Generic
ELITE PHARMS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | Q3 2026 | — | 0.01 | — | $31.6M | — | +0.00% | -8.16% | -13.83% |
| 2025-11-14 | Q2 2026 | — | 0.01 | — | $36.3M | — | — | — | — |
| 2025-08-14 | Q1 2026 |
| — |
| -0.01 |
| — |
| $40.2M |
| — |
| +0.00% |
| +4.76% |
| +31.94% |
| 2025-02-13 | Q3 2025 | — | -0.01 | — | $14.4M | — | -3.99% | -9.96% | -12.14% |
| 2024-11-14 | Q2 2025 | — | -0.01 | — | $18.9M | — | +8.46% | +19.32% | -3.61% |
| 2024-08-14 | Q1 2025 | — | 0.00 | — | $18.8M | — | -3.97% | -2.51% | +80.95% |
| 2024-07-01 | Q4 2024 | — | 0.00 | — | $17.9M | — | -6.45% | -5.95% | -6.95% |
| 2024-02-14 | Q3 2024 | — | 0.00 | — | $15.5M | — | — | — | — |
Showing last 8 quarters.